Molecular Diagnostics News on lab-developed tests and emerging diagnostic technologies. Jan 23, 2023 Genetic Testing Challenges in Oncology: Patient With Pending Bill Has BRCA1 Result Withheld Jan 23, 2023 Quest Diagnostics to Offer Agilent Companion Test for Mirati Therapeutics NSCLC Treatment Jan 19, 2023 Colorectal Cancer Detection Data from CellMax Life Bodes Well for Planned FDA Bid Premium Jan 19, 2023 Invitae Bets on Oncology Portfolio to Drive Growth as it Streamlines, Integrates Test Services Premium Jan 19, 2023 Guardant Health, Royal Marsden Partner on Prospective Liquid Biopsy Trial in Early Colorectal Cancer Jan 19, 2023 Foundation Medicine, Boehringer Ingelheim Collaborate on CDx for Biliary Tract Cancer Drug Jan 19, 2023 Caris Life Sciences Raises $400M in Senior Secured Debt Financing Jan 18, 2023 Freenome Partners With Geisinger to Recruit Patients for Multi-Cancer Screening Study Jan 18, 2023 Genetron Regains Compliance With Nasdaq Listing Requirement Jan 17, 2023 Inflammatory Gene Expression Score IDs High-Risk AML Patients Premium Jan 17, 2023 PamGene, Alithea Genomics, Lausanne University get €1M for Pan-Cancer Blood Test Jan 12, 2023 JP Morgan Healthcare Conference, Day 3: Iovance Biotherapeutics, Biomea Fusion, ADC Therapeutics Jan 11, 2023 Natera Eyes Regulatory Path for Signatera as Companion Diagnostic Jan 10, 2023 Could PD-L1/2 Structural Variants be the Next Pan-Cancer Predictive Immunotherapy Biomarker? Premium Jan 10, 2023 JP Morgan Healthcare Conference, Day 1: Novartis, Bristol Myers Squibb, Mirati, Johnson & Johnson Jan 10, 2023 Myriad Genetics Highlights 2023 Product Launches for Women's Health, Oncology Businesses Premium Jan 10, 2023 Sophia Genetics to Commercialize MSK-ACCESS Clinical Liquid Biopsy Test Jan 10, 2023 Foundation Medicine, Karyopharm Therapeutics Partnering on Endometrial Cancer CDx Jan 6, 2023 In Brief This Week: Datar Cancer Genetics, Daiichi Sankyo, ProPhase Labs, Innovent Biologics Jan 4, 2023 Absent Resolution on FDA's LDT Oversight in 2022, Some Payors Began Advancing Their Own Requirements Premium Load More Breaking News Marengo Therapeutics Begins Phase I/II Trial of Selective T-Cell-Targeted Antibody Janssen, Legend Biotech's Carvykti Bests Chemo in Earlier-Line Multiple Myeloma Trial In Brief This Week: PreludeDx, Johnson & Johnson, Syros, Magenta, Merck NICE Backs Gilead Sciences' Yescarta as Third-Line Option for Lymphoma Patients BMS Eyeing Breyanzi Indications in CLL, SLL After Positive Trial Data Enhertu Approved in Europe for HER2-Low Metastatic Breast Cancer What's Popular? In Molecular Diagnostics Genetic Testing Challenges in Oncology: Patient With Pending Bill Has BRCA1 Result Withheld New Study Results Boost Evidence for Natera's MRD Assays to Guide Adjuvant Therapy Decisions Premium JP Morgan Healthcare Conference, Day 1: Novartis, Bristol Myers Squibb, Mirati, Johnson & Johnson Thermo Fisher Scientific, AstraZeneca to Develop Solid Tissue and Blood-Based CDx Test Labcorp, VieCure Collaborate on NGS, Software for Cancer Diagnosis
